MicroRNA-7: a promising new target in cancer therapy

Juanjuan Zhao1, Yijing Tao1, Ya Zhou2

  • 1Department of Immunology, Zunyi Medical College, Guizhou, 563000 People's Republic of China.

Cancer Cell International
|October 31, 2015
PubMed

Insights

MicroRNA-7 (miR-7) acts as a crucial tumor suppressor, impacting cancer growth and metastasis. Understanding miR-7

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Rising incidence of life-threatening tumors necessitates understanding underlying mechanisms.
  • MicroRNA-7 (miR-7), a small non-coding RNA, is implicated in tumor development.
  • miR-7 functions as a key tumor suppressor in various cancers.

Purpose of the Study:

  • To review the current understanding of microRNA-7's role in tumor development.
  • To explore miR-7's involvement in cancer diagnosis and treatment strategies.
  • To highlight miR-7 as a potential therapeutic target for malignant tumors.

Main Methods:

  • Literature review of recent studies on miR-7 and cancer.
  • Analysis of mechanistic evidence linking miR-7 to tumor progression.
  • Synthesis of data on miR-7's diagnostic and therapeutic implications.

Main Results:

  • miR-7 is closely associated with the growth, metastasis, and prognosis of malignant tumors.
  • miR-7 regulates various target molecules involved in cancer pathways.
  • Evidence suggests miR-7's critical role in the occurrence and development of tumors.

Conclusions:

  • microRNA-7 (miR-7) is a significant tumor suppressor with implications for cancer.
  • miR-7's regulatory functions in tumor growth and metastasis highlight its importance.
  • miR-7 presents a promising target for future clinical diagnosis and cancer treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
MicroRNAs01:22

MicroRNAs

12.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K